403 related articles for article (PubMed ID: 26174047)
1. Transforming berberine into its intestine-absorbable form by the gut microbiota.
Feng R; Shou JW; Zhao ZX; He CY; Ma C; Huang M; Fu J; Tan XS; Li XY; Wen BY; Chen X; Yang XY; Ren G; Lin Y; Chen Y; You XF; Wang Y; Jiang JD
Sci Rep; 2015 Jul; 5():12155. PubMed ID: 26174047
[TBL] [Abstract][Full Text] [Related]
2. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.
Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD
Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration.
Feng R; Zhao ZX; Ma SR; Guo F; Wang Y; Jiang JD
Front Pharmacol; 2018; 9():214. PubMed ID: 29618977
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the transformation of the traditional medicine berberine by bacterial nitroreductase.
Wen HY; Pan LB; Ma SR; Yang XY; Hu JC; Zhao HF; Gao ZQ; Dong YH; Wang Y; Zhang H
Acta Crystallogr D Struct Biol; 2022 Oct; 78(Pt 10):1273-1282. PubMed ID: 36189746
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by berberine using gas-chromatography combined with polymerase chain reaction.
Wang LL; Guo HH; Huang S; Feng CL; Han YX; Jiang JD
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul; 1057():70-80. PubMed ID: 28505492
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.
Buchanan B; Meng Q; Poulin MM; Zuccolo J; Azike CG; Gabriele J; Baranowski DC
PLoS One; 2018; 13(3):e0194979. PubMed ID: 29579096
[TBL] [Abstract][Full Text] [Related]
7. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models.
Cheng Z; Chen AF; Wu F; Sheng L; Zhang HK; Gu M; Li YY; Zhang LN; Hu LH; Li JY; Li J
Bioorg Med Chem; 2010 Aug; 18(16):5915-24. PubMed ID: 20663675
[TBL] [Abstract][Full Text] [Related]
8. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
Shan YQ; Ren G; Wang YX; Pang J; Zhao ZY; Yao J; You XF; Si SY; Song DQ; Kong WJ; Jiang JD
Metabolism; 2013 Mar; 62(3):446-56. PubMed ID: 23079743
[TBL] [Abstract][Full Text] [Related]
9. Dose-response effect of berberine on bile acid profile and gut microbiota in mice.
Guo Y; Zhang Y; Huang W; Selwyn FP; Klaassen CD
BMC Complement Altern Med; 2016 Oct; 16(1):394. PubMed ID: 27756364
[TBL] [Abstract][Full Text] [Related]
10. Excretion of berberine and its metabolites in oral administration in rats.
Ma JY; Feng R; Tan XS; Ma C; Shou JW; Fu J; Huang M; He CY; Chen SN; Zhao ZX; He WY; Wang Y; Jiang JD
J Pharm Sci; 2013 Nov; 102(11):4181-92. PubMed ID: 24006193
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Berberine on the Gut Microbiota in Apc
Wang H; Guan L; Li J; Lai M; Wen X
Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
[No Abstract] [Full Text] [Related]
12. Improvement of intestinal transport, absorption and anti-diabetic efficacy of berberine by using Gelucire44/14: In vitro, in situ and in vivo studies.
Sun J; Bao H; Peng Y; Zhang H; Sun Y; Qi J; Zhang H; Gao Y
Int J Pharm; 2018 Jun; 544(1):46-54. PubMed ID: 29654898
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.
Wang Y; Tong Q; Shou JW; Zhao ZX; Li XY; Zhang XF; Ma SR; He CY; Lin Y; Wen BY; Guo F; Fu J; Jiang JD
Theranostics; 2017; 7(9):2443-2451. PubMed ID: 28744326
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between metformin and berberine in rats: Role of oral administration sequences and microbiota.
Lyu Y; Zhang Y; Yang M; Lin L; Yang X; Cheung SCK; Shaw PC; Chan PKS; Kong APS; Zuo Z
Life Sci; 2019 Oct; 235():116818. PubMed ID: 31473193
[TBL] [Abstract][Full Text] [Related]
15. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.
Chen H; Zhang F; Li R; Liu Y; Wang X; Zhang X; Xu C; Li Y; Guo Y; Yao Q
Biomed Pharmacother; 2020 Apr; 124():109829. PubMed ID: 31958765
[TBL] [Abstract][Full Text] [Related]
16. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways.
Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z
Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788
[TBL] [Abstract][Full Text] [Related]
17. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S
Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374
[TBL] [Abstract][Full Text] [Related]
18. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
19. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
Turner N; Li JY; Gosby A; To SW; Cheng Z; Miyoshi H; Taketo MM; Cooney GJ; Kraegen EW; James DE; Hu LH; Li J; Ye JM
Diabetes; 2008 May; 57(5):1414-8. PubMed ID: 18285556
[TBL] [Abstract][Full Text] [Related]
20. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
Fang Y; Zhang J; Zhu S; He M; Ma S; Jia Q; Sun Q; Song L; Wang Y; Duan L
Pharmacol Res; 2021 Mar; 165():105439. PubMed ID: 33493658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]